Theodore R Schroeder Insider Trading $CADX CADENCE PHARMACEUTICALS INC
Get free email notifications about insider trading for Theodore R Schroeder.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Theodore R Schroeder. Theodore R Schroeder is Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and President, CEO in CADENCE PHARMACEUTICALS INC ($CADX) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Otonomy, Inc. ($OTIC) and in Cidara Therapeutics, Inc. ($CDTX) and Director in Cidara Therapeutics, Inc. ($CDTX) and Chief Executive Officer in Nabriva Therapeutics plc ($NBRV) and Chief Executive Officer) in Nabriva Therapeutics plc ($NBRV).
Theodore R Schroeder in CADENCE PHARMACEUTICALS INC
Trading Symbol: CADXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Theodore R Schroeder: President, CEO
Holdings: 0 shares
Latest Transaction: Mar 21 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Theodore R Schroeder in CADENCE PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CADX, CDTX, COLL, HPTX, NBRV, OTIC
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 0.00 | 400,000 | 0 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 5.40 | 400,000 | 2,160,000 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 3.51 | 164,074 | 575,900 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 3.51 | 350,000 | 1,228,500 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 8.55 | 500,000 | 4,275,000 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 9.22 | 150,000 | 1,383,000 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 9.22 | 35,000 | 322,700 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 8.35 | 200,000 | 1,670,000 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 6.01 | 400,000 | 2,404,000 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 15.13 | 100,000 | 1,513,000 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 1.36 | 510,935 | 694,872 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | U | 14.00 | 307,500 | 4,305,000 | 0 | 307.5 K to 0 (-100.00 %) |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | U | 14.00 | 12,664 | 177,296 | 0 | 12.7 K to 0 (-100.00 %) |
Feb 12 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 0.00 | 400,000 | 0 | 400,000 | |
Mar 15 2013 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 5.40 | 400,000 | 2,160,000 | 400,000 | |
Mar 16 2012 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 3.51 | 164,074 | 575,900 | 164,074 | |
Mar 16 2012 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 3.51 | 350,000 | 1,228,500 | 350,000 | |
Nov 04 2011 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
Nov 04 2011 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Payment of Exercise | F | 5.72 | 7,336 | 41,962 | 12,664 | 20 K to 12.7 K (-36.68 %) |
Nov 04 2011 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Buy | M | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
May 17 2011 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Buy | P | 7.48 | 16,000 | 119,626 | 307,500 | 291.5 K to 307.5 K (+5.49 %) |
Mar 18 2011 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 8.55 | 500,000 | 4,275,000 | 500,000 | |
Oct 04 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 8.35 | 9,297 | 77,670 | 311,000 | 320.3 K to 311 K (-2.90 %) |
Oct 04 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 8.35 | 40,703 | 339,691 | 320,297 | 361 K to 320.3 K (-11.28 %) |
Jul 01 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 6.95 | 8,979 | 62,401 | 361,000 | 370 K to 361 K (-2.43 %) |
Jul 01 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 7.00 | 41,021 | 287,250 | 369,979 | 411 K to 370 K (-9.98 %) |
Apr 01 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 9.03 | 21,997 | 198,626 | 411,000 | 433 K to 411 K (-5.08 %) |
Apr 01 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 9.30 | 28,003 | 260,330 | 432,997 | 461 K to 433 K (-6.07 %) |
Mar 29 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 9.22 | 35,000 | 322,700 | 185,000 | |
Mar 29 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 9.22 | 150,000 | 1,383,000 | 150,000 | |
Jan 04 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 9.80 | 10,343 | 101,363 | 461,000 | 471.3 K to 461 K (-2.19 %) |
Jan 04 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 9.76 | 19,657 | 191,866 | 471,343 | 491 K to 471.3 K (-4.00 %) |
Oct 19 2009 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 10.72 | 20,000 | 214,376 | 491,000 | 511 K to 491 K (-3.91 %) |
Sep 02 2009 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Mar 20 2009 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 8.35 | 200,000 | 1,670,000 | 200,000 | |
Mar 20 2008 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 6.01 | 400,000 | 2,404,000 | 400,000 | |
Feb 22 2008 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Grant | A | 5.34 | 11,000 | 58,740 | 511,000 | 500 K to 511 K (+2.20 %) |
Mar 26 2007 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 15.13 | 100,000 | 1,513,000 | 100,000 |
Page: 1